» Articles » PMID: 28781670

Targeting of Angiopoietin 2-small Interfering RNA Plasmid/chitosan Magnetic Nanoparticles in a Mouse Model of Malignant Melanoma

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Aug 8
PMID 28781670
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to observe the targeting characteristic of angiopoietin 2-small interfering RNA (Ang2-siRNA) plasmid/chitosan magnetic nanoparticles in an established nude mouse model of malignant melanoma (MM) under an external magnetic field. The nude mouse MM model was first established, then divided into 3 groups, including the control group, the non-targeting group and the target group, the control group was given normal saline and the non-targeting and targeting groups were administrated particles through the tail vein; the non-targeting group was not under external magnetic field and the control group and the targeting group were under external magnetic field for 60 min. The mice were then sacrificed and the tumor tissues were stained with hematoxylin and eosin and Prussian blue in order to verify the particle distributions in the tumor tissues. The control group exhibited negative Prussian blue staining in the tumor tissues, the non-targeting group demonstrated weakly positive Prussian blue staining in tumor tissues and the targeting group revealed strongly positive Prussian blue staining in tumor tissues. Ang2-siRNA plasmid vector/chitosan magnetic nanoparticles directly moved towards tumor tissues under the action of external magnetic field, thus it demonstrated good targeting characteristic.

Citing Articles

Pathological impact and medical applications of electromagnetic field on melanoma: A focused review.

Duan Y, Wu X, Gong Z, Guo Q, Kong Y Front Oncol. 2022; 12:857068.

PMID: 35936711 PMC: 9355252. DOI: 10.3389/fonc.2022.857068.


Magnetofection In Vivo by Nanomagnetic Carriers Systemically Administered into the Bloodstream.

Sizikov A, Nikitin P, Nikitin M Pharmaceutics. 2021; 13(11).

PMID: 34834342 PMC: 8619128. DOI: 10.3390/pharmaceutics13111927.


Effect of Chitosan Magnetic Nanoparticles Loaded with Ang2-siRNA Plasmids on the Growth of Melanoma Xenografts in Nude Mice.

Shan X, Yu W, Ni X, Xu T, Lei C, Liu Z Cancer Manag Res. 2020; 12:7475-7485.

PMID: 32904466 PMC: 7455758. DOI: 10.2147/CMAR.S250479.

References
1.
Yu B, Tai H, Xue W, Lee L, Lee R . Receptor-targeted nanocarriers for therapeutic delivery to cancer. Mol Membr Biol. 2010; 27(7):286-98. PMC: 3789246. DOI: 10.3109/09687688.2010.521200. View

2.
Zeinali Sehrig F, Majidi S, Nikzamir N, Nikzamir N, Nikzamir M, Akbarzadeh A . Magnetic nanoparticles as potential candidates for biomedical and biological applications. Artif Cells Nanomed Biotechnol. 2015; 44(3):918-27. DOI: 10.3109/21691401.2014.998832. View

3.
Dong X, Mumper R . Nanomedicinal strategies to treat multidrug-resistant tumors: current progress. Nanomedicine (Lond). 2010; 5(4):597-615. PMC: 2925023. DOI: 10.2217/nnm.10.35. View

4.
Maruyama K . Intracellular targeting delivery of liposomal drugs to solid tumors based on EPR effects. Adv Drug Deliv Rev. 2010; 63(3):161-9. DOI: 10.1016/j.addr.2010.09.003. View

5.
Ishii T, Okahata Y, Sato T . Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 2001; 1514(1):51-64. DOI: 10.1016/s0005-2736(01)00362-5. View